NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,711,306 | -87.3% | 16,801 | -87.4% | 0.13% | -86.6% |
| Q2 2023 | $13,440,059 | +6.2% | 133,189 | -3.2% | 0.99% | +1.6% |
| Q1 2023 | $12,657,228 | +1.7% | 137,579 | +0.3% | 0.98% | -0.5% |
| Q4 2022 | $12,446,200 | +19.3% | 137,194 | -0.1% | 0.98% | +9.0% |
| Q3 2022 | $10,437,000 | -9.3% | 137,308 | +0.9% | 0.90% | +0.2% |
| Q2 2022 | $11,506,000 | -3.9% | 136,114 | -0.2% | 0.90% | +9.5% |
| Q1 2022 | $11,970,000 | -0.8% | 136,411 | -1.1% | 0.82% | +3.9% |
| Q4 2021 | $12,070,000 | +6.0% | 137,986 | -0.9% | 0.79% | -2.6% |
| Q3 2021 | $11,390,000 | -10.0% | 139,277 | +0.4% | 0.81% | -10.8% |
| Q2 2021 | $12,653,000 | +6.5% | 138,676 | -0.2% | 0.91% | -1.9% |
| Q1 2021 | $11,879,000 | -11.8% | 138,968 | -2.6% | 0.93% | -17.5% |
| Q4 2020 | $13,470,000 | +9.6% | 142,649 | +0.9% | 1.12% | -1.4% |
| Q3 2020 | $12,289,000 | -0.4% | 141,314 | +0.0% | 1.14% | -9.8% |
| Q2 2020 | $12,339,000 | +11.2% | 141,274 | +4.9% | 1.26% | -4.9% |
| Q1 2020 | $11,100,000 | +602.5% | 134,625 | +706.8% | 1.33% | +769.3% |
| Q4 2019 | $1,580,000 | +8.7% | 16,687 | -0.3% | 0.15% | +2.0% |
| Q3 2019 | $1,454,000 | -11.2% | 16,732 | -6.7% | 0.15% | -11.8% |
| Q2 2019 | $1,637,000 | -10.1% | 17,932 | -5.3% | 0.17% | -16.3% |
| Q1 2019 | $1,820,000 | +10.3% | 18,933 | -1.5% | 0.20% | -0.5% |
| Q4 2018 | $1,650,000 | -1.9% | 19,223 | -1.5% | 0.20% | +14.0% |
| Q3 2018 | $1,682,000 | +26.0% | 19,523 | +10.4% | 0.18% | +17.0% |
| Q2 2018 | $1,335,000 | -9.4% | 17,678 | -3.0% | 0.15% | -11.6% |
| Q1 2018 | $1,474,000 | -8.0% | 18,228 | -4.5% | 0.17% | -4.9% |
| Q4 2017 | $1,603,000 | -12.4% | 19,093 | -10.4% | 0.18% | -17.6% |
| Q3 2017 | $1,829,000 | +2.9% | 21,303 | 0.0% | 0.22% | +3.3% |
| Q2 2017 | $1,778,000 | +4.0% | 21,303 | -7.4% | 0.21% | +3.9% |
| Q1 2017 | $1,709,000 | -28.5% | 23,013 | -29.9% | 0.21% | -33.3% |
| Q4 2016 | $2,390,000 | -79.1% | 32,806 | -77.4% | 0.31% | -78.8% |
| Q3 2016 | $11,441,000 | -1.0% | 144,895 | +3.4% | 1.46% | -5.6% |
| Q2 2016 | $11,560,000 | +35.5% | 140,105 | +19.0% | 1.55% | +30.3% |
| Q1 2016 | $8,530,000 | +2016.6% | 117,763 | +2412.0% | 1.19% | +1982.5% |
| Q4 2015 | $403,000 | -5.0% | 4,688 | +1.4% | 0.06% | -8.1% |
| Q3 2015 | $424,000 | -1.2% | 4,623 | +5.9% | 0.06% | +8.8% |
| Q2 2015 | $429,000 | +9.4% | 4,367 | +9.8% | 0.06% | +7.5% |
| Q1 2015 | $392,000 | -7.8% | 3,977 | -13.4% | 0.05% | -7.0% |
| Q4 2014 | $425,000 | +15.2% | 4,592 | +16.9% | 0.06% | +11.8% |
| Q3 2014 | $369,000 | +3.1% | 3,929 | -0.9% | 0.05% | +8.5% |
| Q2 2014 | $358,000 | +5.6% | 3,964 | -0.9% | 0.05% | -2.1% |
| Q1 2014 | $339,000 | +5.6% | 3,999 | 0.0% | 0.05% | +2.1% |
| Q4 2013 | $321,000 | +4.9% | 3,999 | 0.0% | 0.05% | -4.1% |
| Q3 2013 | $306,000 | +8.5% | 3,999 | 0.0% | 0.05% | +6.5% |
| Q2 2013 | $282,000 | – | 3,999 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |